Aksotilin – a psychostimulant, the means applied at a syndrome of deficit of attention and hyperactivity (ADHD), nootropic means.

Indications

Stroke, sharp phase of disturbances of cerebral circulation and neurologic consequences.

Craniocereberal injury and its neurologic consequences.

Cognitive disturbances and behavior disorders as a result of chronic vascular and degenerative cerebral disorders.

Structure

• active ingredient: citicoline;
• 1 tablet supports a tsitikolin (in the form of a tsitikolin of sodium) – 500 mg;
• other components: microcrystalline cellulose, sodium of a kroskarmeloz, silicon dioxide colloidal anhydrous, the castor oil hydrogenated, talc, magnesium stearate;
• cover: polyvinyl alcohol, titan dioxide (E 171), talc, hydrosodium carbonate, polyethyleneglycol (4000) (macrogoal), methacrylate copolymer (type A).

Contraindication

Hypersensitivity to a tsitikolin or other components of medicine.

High tone of parasympathetic nervous system.

Side reactions

from hallucination mentality.

from nervous system: severe headache, dizziness.

from a cardiovascular system: arterial hypertension, arterial hypotension.

from a respiratory system: dispnoe.

from a digestive tract: nausea, vomiting, incidental diarrhea.

from skin and hypodermic cellulose: allergic reactions, including rash, an itching, a Quincke's disease, an acute anaphylaxis, reddening, a small tortoiseshell, a dieback, a purpura.

General disturbances: fever, hypostasis.

Route of administration

Recommended dose makes from 500 to 2000 mg/days (1–4 tablets) depending on weight of symptoms and a condition of the patient.

Dose of medicament and terms of treatment are established by the doctor.

Patients of advanced age do not need correction of a dose.

Children. Experience of use of a tsitikolin to children is limited therefore medicine is appointed only when the expected advantage prevails on any potential risk.

Feature of use

Medicine contains the ricinic oil hydrogenated that can cause indigestions and diarrhea. Therefore patients with inflammatory bowel diseases should use medicament with extra care.

Use during pregnancy or feeding by a breast

Is not present sufficient data on use of a tsitikolin to pregnant women. Tsitikolin it is not necessary to apply during pregnancy, except need cases. During pregnancy medicine is appointed only when the expected therapeutic advantage exceeds potential risk. There are no data on penetration of a tsitikolin into breast milk and on its action on a fruit.

Experience of use of a tsitikolin to children is limited to

therefore medicine is appointed only when the expected advantage prevails on any potential risk.

Ability to influence speed of response at control of motor transport or other mechanisms

In individual cases some side reactions from central nervous system can affect ability to run motor transport or to work with difficult mechanisms.

Cases of overdose are noted by

.

Interaction with other medicines and other types of interactions

Tsitikolin enhances effect of a levodopa.

along with the medicines containing Meclofenoxatum.

Storage conditions

In original packing at a temperature not above 25 °C.

out of children's reach!